Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
5.05
-0.02 (-0.39%)
Apr 9, 2026, 3:04 PM CST
Market Cap5.36B +36.9%
Revenue (ttm)2.49B +3.0%
Net Income-677.20M
EPS-0.64
Shares Out1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41,614,500
Average Volume20,170,385
Open5.01
Previous Close5.07
Day's Range5.01 - 5.36
52-Week Range3.28 - 6.74
Beta0.44
RSI55.88
Earnings DateApr 22, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1998
Employees 3,196
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2024, SHE:002793's revenue was 2.65 billion, an increase of 11.99% compared to the previous year's 2.36 billion. Losses were -965.50 million, 46.0% more than in 2023.

Financial Statements